{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:44:43Z","timestamp":1782787483060,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04875-w","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:45:02Z","timestamp":1778150702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term efficacy of combined phacoemulsification and Hydrus microstent in open-angle glaucoma versus combined-mechanism\/primary angle closure glaucoma: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Kelly C.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunee","family":"Chansangpetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Iwach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"10414","key":"4875_CR1","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS, Gazzard G. Glaucoma: now and beyond. Lancet. 2023;402(10414):1788\u2013801. https:\/\/doi.org\/10.1016\/S0140-6736(23)01289-8.","journal-title":"Lancet"},{"issue":"4","key":"4875_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ceo.12888","volume":"45","author":"NM Kerr","year":"2017","unstructured":"Kerr NM, Wang J, Barton K. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma. Clin Exp Ophthalmol. 2017;45(4):393\u2013400. https:\/\/doi.org\/10.1111\/ceo.12888.","journal-title":"Clin Exp Ophthalmol"},{"issue":"12","key":"4875_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1080\/17434440.2023.2259788","volume":"20","author":"AM Fea","year":"2023","unstructured":"Fea AM, Ricardi F, Cariola R, Rossi A. Hydrus microstent for the treatment of primary open-angle glaucoma: overview of its safety and efficacy. Expert Rev Med Devices. 2023;20(12):1009\u201325. https:\/\/doi.org\/10.1080\/17434440.2023.2259788.","journal-title":"Expert Rev Med Devices"},{"issue":"6","key":"4875_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ophtha.2020.11.004","volume":"128","author":"IIK Ahmed","year":"2021","unstructured":"Ahmed IIK, Rhee DJ, Jones J, et al. Three-Year Findings of the HORIZON Trial: A Schlemm Canal Microstent for Pressure Reduction in Primary Open-Angle Glaucoma and Cataract. Ophthalmology. 2021;128(6):857\u201365. https:\/\/doi.org\/10.1016\/j.ophtha.2020.11.004.","journal-title":"Ophthalmology"},{"issue":"1","key":"4875_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ophtha.2019.04.034","volume":"127","author":"IIK Ahmed","year":"2020","unstructured":"Ahmed IIK, Fea A, Au L, et al. A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study. Ophthalmology. 2020;127(1):52\u201361. https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.034.","journal-title":"Ophthalmology"},{"key":"4875_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.preteyeres.2016.12.003","volume":"57","author":"X Sun","year":"2017","unstructured":"Sun X, Dai Y, Chen Y, et al. Primary angle closure glaucoma: What we know and what we don\u2019t know. Prog Retin Eye Res. 2017;57:26\u201345. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.12.003.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"4875_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3109\/02713683.2011.584009","volume":"36","author":"PH Peng","year":"2011","unstructured":"Peng PH, Manivanh R, Nguyen N, Weinreb RN, Lin SC. Glaucoma and clinical characteristics in Vietnamese Americans. Curr Eye Res. 2011;36(8):733\u20138. https:\/\/doi.org\/10.3109\/02713683.2011.584009.","journal-title":"Curr Eye Res"},{"issue":"1","key":"4875_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1120672119879331","volume":"31","author":"S Shokoohi-Rad","year":"2021","unstructured":"Shokoohi-Rad S, Karimi F, Zarei-Ghanavati S, Tireh H. Phacoemulsification, visco-goniosynechialysis, and goniotomy in patients with primary angle-closure glaucoma: A comparative study. Eur J Ophthalmol. 2021;31(1):88\u201395. https:\/\/doi.org\/10.1177\/1120672119879331.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"4875_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/ICU.0000000000001117","volume":"36","author":"NS Chan","year":"2025","unstructured":"Chan NS, Sng CCA. Minimally invasive glaucoma surgery in angle closure. Curr Opin Ophthalmol. 2025;36(2):152\u20138. https:\/\/doi.org\/10.1097\/ICU.0000000000001117.","journal-title":"Curr Opin Ophthalmol"},{"key":"4875_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajo.2018.08.003","volume":"195","author":"S Chansangpetch","year":"2018","unstructured":"Chansangpetch S, Lau K, Perez CI, Nguyen N, Porco TC, Lin SC. Efficacy of Cataract Surgery With Trabecular Microbypass Stent Implantation in Combined-Mechanism Angle Closure Glaucoma Patients. Am J Ophthalmol. 2018;195:191\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2018.08.003.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"4875_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/IJG.0b013e31821dac66","volume":"21","author":"M Ng","year":"2012","unstructured":"Ng M, Sample PA, Pascual JP, et al. Comparison of visual field severity classification systems for glaucoma. J Glaucoma. 2012;21(8):551\u201361. https:\/\/doi.org\/10.1097\/IJG.0b013e31821dac66.","journal-title":"J Glaucoma"},{"issue":"7","key":"4875_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/IJG.0000000000001542","volume":"29","author":"S Chansangpetch","year":"2020","unstructured":"Chansangpetch S, Ittarat M, Yang S, et al. Comparison of 1-Year Effectiveness of Trabecular Microbypass Stent implantation (iStent) in Conjunction With Phacoemulsification Among Mild, Moderate, and Severe Primary Open-angle Glaucoma Patients. J Glaucoma. 2020;29(7):542\u20139. https:\/\/doi.org\/10.1097\/IJG.0000000000001542.","journal-title":"J Glaucoma"},{"issue":"1","key":"4875_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/IJG.0000000000000825","volume":"27","author":"T Ferguson","year":"2018","unstructured":"Ferguson T, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Evaluation of a Trabecular Microbypass Stent With Cataract Extraction in Severe Primary Open-angle Glaucoma. J Glaucoma. 2018;27(1):71\u20136. https:\/\/doi.org\/10.1097\/IJG.0000000000000825.","journal-title":"J Glaucoma"},{"issue":"2","key":"4875_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10384-022-00971-8","volume":"67","author":"D Sakai","year":"2023","unstructured":"Sakai D, Yamamoto S, Yoshimizu S, et al. Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure disease. Jpn J Ophthalmol. 2023;67(2):129\u201337. https:\/\/doi.org\/10.1007\/s10384-022-00971-8.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"4875_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ophtha.2005.11.018","volume":"113","author":"A Nonaka","year":"2006","unstructured":"Nonaka A, Kondo T, Kikuchi M, et al. Angle widening and alteration of ciliary process configuration after cataract surgery for primary angle closure. Ophthalmology. 2006;113(3):437\u201341. https:\/\/doi.org\/10.1016\/j.ophtha.2005.11.018.","journal-title":"Ophthalmology"},{"key":"4875_CR16","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.2147\/OPTH.S373290","volume":"16","author":"C Clement","year":"2022","unstructured":"Clement C, Howes F, Ioannidis A, et al. Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension. Clin Ophthalmol. 2022;16:2955\u201368. https:\/\/doi.org\/10.2147\/OPTH.S373290. Published 2022 Sep 1.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"4875_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jnma.2020.04.003","volume":"112","author":"D Laroche","year":"2020","unstructured":"Laroche D, Brown A, Ng C. Clear Lensectomy, Goniosynechiolysis and Hydrus Microstent in a Patient with Mixed Mechanism Glaucoma. J Natl Med Assoc. 2020;112(4):339\u201343. https:\/\/doi.org\/10.1016\/j.jnma.2020.04.003.","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"4875_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ophtha.2018.05.012","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Chang DF, Marquis R, et al. A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract: The HORIZON Study. Ophthalmology. 2019;126(1):29\u201337. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.012.","journal-title":"Ophthalmology"},{"issue":"7","key":"4875_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ophtha.2015.03.031","volume":"122","author":"N Pfeiffer","year":"2015","unstructured":"Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. A randomized trial of a schlemm\u2019s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122(7):1283\u201393. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.031.","journal-title":"Ophthalmology"},{"key":"4875_CR20","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.2147\/OPTH.S538439","volume":"19","author":"K Nguyen","year":"2025","unstructured":"Nguyen K, Chansangpetch S, Vinh MK, Tran AQH, Radhakrishnan S, Nguyen N, Iwach AG, Lin S. Efficacy of combined phacoemulsification and hydrus microstent in open-angle glaucoma versus combined-mechanism\/primary angle closure glaucoma. Clin Ophthalmol (Auckland N Z). 2025;19:3347\u201356. https:\/\/doi.org\/10.2147\/OPTH.S538439.","journal-title":"Clin Ophthalmol (Auckland N Z)"},{"issue":"7","key":"4875_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","volume":"129","author":"IIK Ahmed","year":"2022","unstructured":"Ahmed IIK, De Francesco T, Rhee D, et al. Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm\u2019s Canal Microstent in Combination Cataract and Glaucoma Surgery. Ophthalmology. 2022;129(7):742\u201351. https:\/\/doi.org\/10.1016\/j.ophtha.2022.02.021.","journal-title":"Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04875-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:17:51Z","timestamp":1782785871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04875-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4875"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04875-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for ethical approval was exempted by the institutional review board (IRB) [Advarra, Columbia, MD] due to the retrospective study design and inability of subjects to provide informed consent. Therefore, the need for consent was deemed unnecessary and waived by the IRB. The study was conducted in accordance with the principles of the Declaration of Helsinki for research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Shan C. Lin is a consultant for Santen, IRIDEX, Bausch & Lomb, and iSTAR and a speaker for Santen and Bausch & Lomb. Sunita Radhakrishnan is a consultant for Netra Systems Inc. Andrew G. Iwach is a consultant and advisor for Alcon Laboratories, Inc., public equity and stockholder for Eyenovia, public equity and stockholder for Eli Lilly & Company, and board member for Ophthalmic Mutual Insurance Company. The following authors have no financial disclosures: Kelly Nguyen, Eden Ng, Sunee Chansangpetch, and Ngoc Nguyen.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"361"}}